IP Library Patent Application 14161967
Patent Application
App. No. 14/161,967

NOVEL POLYMORPHIC FORMS OF PERINDOPRIL (L)-ARGININE AND PROCESS FOR THE PREPARATION THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/161,967
Abstract

The present invention relates to novel and stable polymorphic forms of Perindopril (L)-Arginine designated as Form γ and amorphous form and processes for their preparation. The present invention also provides the novel polymorph Form γ with greater stability to heat and humidity and can be prepared on large scale by an efficient, economic and reproducible process.

Claims (24)

1 . Amorphous form of Perindopril (L)-Arginine.

2 . The amorphous form of Perindopril (L)-Arginine according to claim 1 , having a powder X-ray diffraction pattern as shown in FIG. 2 .

3 . The amorphous form of Perindopril (L)-Arginine according to claim 1 characterized by a glass transition temperature (Tg) at about 96° C. in DSC as shown in FIG. 3 .

4 . A process for the preparation of amorphous Perindopril (L)-Arginine comprising the steps of:

a) dissolving polymorphic form γ of Perindopril (L)-Arginine in a solvent,

b) removing the solvent and

c) isolating the amorphous Perindopril (L)-Arginine.

5 . The process according to claim 4 , wherein the solvent is an alcohol.

6 . The process according to claim 4 , wherein the solvent is methanol.

7 . The process according to claim 4 , wherein the solvent is removed by distillation.

8 . A process for the preparation of amorphous Perindopril (L)-Arginine comprising the steps of:

a) suspending Perindopril free acid in a solvent or mixture of solvents,

b) adding (L)-Arginine and heating the reaction mass to reflux temperature,

c) cooling the solution to 20-30° C. and

d) removing the solvent and isolating amorphous Perindopril (L)-Arginine.

9 . The process according to claim 8 , wherein the solvent is selected from the group consisting of lower alcohols, dichloromethane, water and mixtures thereof.

10 . The process according to claim 9 , wherein the lower alcohol is selected from the group consisting of methanol, ethanol and isopropyl alcohol.

11 . The process according to claim 8 , wherein the solvent is removed by spray drying or by freeze drying.

12 . A process for the preparation of polymorphic form γ of Perindopril (L)-Arginine comprising the steps of:

a) suspending the amorphous Perindopril (L)-Arginine according to claim 1 in a solvent,

b) distilling the suspension azeotropically at a temperature of about 80-110° C.,

c) adding an antisolvent and

d) isolating polymorphic form γ of Perindopril (L)-Arginine.

13 . A process for the preparation of polymorphic form γ of Perindopril (L)-Arginine comprising exposing the amorphous form of Perindopril (L)-Arginine according to claim 1 to a relative humidity of about 90% for several hours.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 033109 FRAME 0516. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jun 26, 2014
From: LIMITTED, MATRIX LABORATORIES
To: MYLAN LABORATORIES LIMITED
Reel/Frame 033244/0557 →
CHANGE OF NAME Recorded Jun 16, 2014
From: LIMITTED, MATRIX LABORATORIES
To: MYLAN LABORATORIES LIMITED
Reel/Frame 033109/0516 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2014
From: JETTI, RAMAKOTESWARA RAO; RAVAL, CHETAN KANAIYALAL; BOMMAREDDY, AGGI RAMIREDDY; DATTA, DEBASHISH
To: MATRIX LABORATORIES LTD
Reel/Frame 033099/0551 →